Summary by Futu AI
SIHUAN PHARM FILED WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 3 JANUARY 2024 WITH THE SECURITIES MONTHLY CHANGE REPORT FOR THE YEAR ENDED 31 DECEMBER 2023. The report showed that the company's regulated/registered share capital and issued shares remained unchanged during the month, at HK$1,000,000,000 and 9,329,999,206 shares. In addition, under the share option plan adopted on October 24, 2017, the Company had 74,110,000 shares outstanding at the end of this month, with no additional issuance. Four Circle Pharmaceuticals confirms that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.